Jeglum KA - Search Results

1

In vivo destruction of canine lymphoma mediated by murine monoclonal antibodies.

Steplewski Z, Rosales C, Jeglum KA, McDonald-Smith J. Steplewski Z, et al. Among authors: jeglum ka. In Vivo. 1990 Jul-Aug;4(4):231-4. In Vivo. 1990. PMID: 2103365

2

Cytolytic activity of murine anti-dog lymphoma monoclonal antibodies with canine effector cells and complement.

Rosales C, Jeglum KA, Obrocka M, Steplewski Z. Rosales C, et al. Among authors: jeglum ka. Cell Immunol. 1988 Sep;115(2):420-8. doi: 10.1016/0008-8749(88)90194-3. Cell Immunol. 1988. PMID: 3409330

3

Canine lymphoma-associated antigens defined by murine monoclonal antibodies.

Steplewski Z, Jeglum KA, Rosales C, Weintraub N. Steplewski Z, et al. Among authors: jeglum ka. Cancer Immunol Immunother. 1987;24(3):197-201. doi: 10.1007/BF00205629. Cancer Immunol Immunother. 1987. PMID: 3594482 Free PMC article.

4

Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma.

Jeglum KA, Young KM, Barnsley K, Whereat A. Jeglum KA, et al. Cancer. 1988 May 15;61(10):2042-50. doi: 10.1002/1097-0142(19880515)61:10<2042::aid-cncr2820611019>3.0.co;2-q. Cancer. 1988. PMID: 3359402

5

Phase I clinical trial with a human major histocompatibility complex nonrestricted cytotoxic T-cell line (TALL-104) in dogs with advanced tumors.

Cesano A, Visonneau S, Jeglum KA, Owen J, Wilkinson K, Carner K, Reese L, Santoli D. Cesano A, et al. Among authors: jeglum ka. Cancer Res. 1996 Jul 1;56(13):3021-9. Cancer Res. 1996. PMID: 8674057 Clinical Trial.

6

Successful treatment of canine malignant histiocytosis with the human major histocompatibility complex nonrestricted cytotoxic T-cell line TALL-104.

Visonneau S, Cesano A, Tran T, Jeglum KA, Santoli D. Visonneau S, et al. Among authors: jeglum ka. Clin Cancer Res. 1997 Oct;3(10):1789-97. Clin Cancer Res. 1997. PMID: 9815565

7

Chemoimmunotherapy of canine lymphoma with adjuvant canine monoclonal antibody 231.

Jeglum KA. Jeglum KA. Vet Clin North Am Small Anim Pract. 1996 Jan;26(1):73-85. doi: 10.1016/s0195-5616(96)50007-0. Vet Clin North Am Small Anim Pract. 1996. PMID: 8825567 Review.

8

Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine.

Van Vechten M, Helfand SC, Jeglum KA. Van Vechten M, et al. Among authors: jeglum ka. J Vet Intern Med. 1990 Jul-Aug;4(4):187-91. doi: 10.1111/j.1939-1676.1990.tb00896.x. J Vet Intern Med. 1990. PMID: 2401965 Free article.

9

Adoptive therapy of canine metastatic mammary carcinoma with the human MHC non-restricted cytotoxic T-cell line TALL-104.

Visonneau S, Cesano A, Jeglum KA, Santoli D. Visonneau S, et al. Among authors: jeglum ka. Oncol Rep. 1999 Nov-Dec;6(6):1181-8. doi: 10.3892/or.6.6.1181. Oncol Rep. 1999. PMID: 10523677

10

In vitro immune monitoring of antibody response in dogs given chemoimmunotherapy for lymphoma.

Jeglum KA, Winters WD, Young KM. Jeglum KA, et al. Am J Vet Res. 1989 Apr;50(4):488-92. Am J Vet Res. 1989. PMID: 2712415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters